| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2012 | AMP-activated protein kinase mediates erythropoietin-induced activation of endothelial nitric oxide synthase. | Su, KH; Yu, YB; Hou, HH; Zhao, JF; Kou, YR; Cheng, LC; Shyue, SK; Lee, TS | Journal of cellular physiology 227(8), 3053-3062 | | | |
| 2008 | Disruption of guanylyl cyclase-G protects against acute renal injury. | Lin, H; Cheng, CF; Hou, HH; Lian, WS; Chao, YC; Ciou, YY; Djoko, B; Tsai, MT; Cheng, CJ; Yang, RB | Journal of the American Society of Nephrology : JASN 19(2), 339-48 | | | |
| 2015 | Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancer. | Liao, WY; Ho, CC; Hou, HH; Hsu, TH; Tsai, MF; Chen, KY; Chen, HY; Lee, YC; Yu, CJ; Lee, CH; Yang, PC | The Journal of pathology 235(1), 50-64 | | | |
| 2012 | Implication of AMP-activated protein kinase in transient receptor potential vanilloid type 1-mediated activation of endothelial nitric oxide synthase | Ching, LC; Chen, CY; Su, KH; Hou, HH; Shyue, SK; Kou, YR; Lee, TS | MOLECULAR MEDICINE 18, 805-815 | | | |
| 2012 | N-terminal domain of soluble epoxide hydrolase negatively regulates the VEGF-mediated activation of endothelial nitric oxide synthase. | Hou, HH; Hammock, BD; Su, KH; Morisseau, C; Kou, YR; Imaoka, S; Oguro, A; Shyue, SK; Zhao, JF; Lee, TS | CARDIOVASCULAR RESEARCH 93(1), 120-129 | | | |
| 2015 | Role of phosphatase activity of soluble epoxide hydrolase in regulating simvastatin-activated endothelial nitric oxide synthase. | Hou, HH; Liao, YJ; Hsiao, SH; Shyue, SK; Lee, TS | Scientific reports 5, 13524 | | | |
| 2009 | Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signalling. | Su, KH; Tsai, JY; Kou, YR; Chiang, AN; Hsiao, SH; Wu, YL; Hou, HH; Pan, CC; Shyue, SK; Lee, TS | Cardiovascular research 82(3), 468-75 | | | |
